Guardant Health Stock Technical Analysis
| GH Stock | USD 104.85 2.09 2.03% |
As of the 17th of February 2026, Guardant Health retains the market risk adjusted performance of 0.1349, and Risk Adjusted Performance of 0.048. Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Guardant Health Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Guardant, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GuardantGuardant Health's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Guardant Health Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 125.24 | Strong Buy | 24 | Odds |
Most Guardant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Guardant Health, talking to its executives and customers, or listening to Guardant conference calls.
Is there potential for Health Care Providers & Services market expansion? Will Guardant introduce new products? Factors like these will boost the valuation of Guardant Health. Market participants price Guardant higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.22) | Revenue Per Share | Quarterly Revenue Growth 0.385 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Guardant Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Guardant Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Guardant Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Guardant Health.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Guardant Health on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Guardant Health or generate 0.0% return on investment in Guardant Health over 90 days. Guardant Health is related to or competes with EXACT Sciences, ICON PLC, Revvity, Ascendis Pharma, Viatris, Qiagen NV, and Ionis Pharmaceuticals. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States... More
Guardant Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Guardant Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Guardant Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.8 | |||
| Information Ratio | 0.0258 | |||
| Maximum Drawdown | 17.61 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 4.16 |
Guardant Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardant Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Guardant Health's standard deviation. In reality, there are many statistical measures that can use Guardant Health historical prices to predict the future Guardant Health's volatility.| Risk Adjusted Performance | 0.048 | |||
| Jensen Alpha | 0.069 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.026 | |||
| Treynor Ratio | 0.1249 |
Guardant Health February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.048 | |||
| Market Risk Adjusted Performance | 0.1349 | |||
| Mean Deviation | 2.02 | |||
| Semi Deviation | 2.64 | |||
| Downside Deviation | 2.8 | |||
| Coefficient Of Variation | 1975.67 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.94 | |||
| Information Ratio | 0.0258 | |||
| Jensen Alpha | 0.069 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.026 | |||
| Treynor Ratio | 0.1249 | |||
| Maximum Drawdown | 17.61 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 4.16 | |||
| Downside Variance | 7.82 | |||
| Semi Variance | 6.96 | |||
| Expected Short fall | (2.10) | |||
| Skewness | 0.2324 | |||
| Kurtosis | 2.31 |
Guardant Health Backtested Returns
Guardant Health is very steady at the moment. Guardant Health holds Efficiency (Sharpe) Ratio of 0.0443, which attests that the entity had a 0.0443 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Guardant Health, which you can use to evaluate the volatility of the firm. Please check out Guardant Health's market risk adjusted performance of 0.1349, and Risk Adjusted Performance of 0.048 to validate if the risk estimate we provide is consistent with the expected return of 0.13%. Guardant Health has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.06, which attests to a somewhat significant risk relative to the market. Guardant Health returns are very sensitive to returns on the market. As the market goes up or down, Guardant Health is expected to follow. Guardant Health right now retains a risk of 2.85%. Please check out Guardant Health sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to decide if Guardant Health will be following its current trending patterns.
Auto-correlation | 0.05 |
Virtually no predictability
Guardant Health has virtually no predictability. Overlapping area represents the amount of predictability between Guardant Health time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Guardant Health price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Guardant Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 22.92 |
Guardant Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Guardant Health Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Guardant Health volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Guardant Health Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Guardant Health on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Guardant Health based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Guardant Health price pattern first instead of the macroeconomic environment surrounding Guardant Health. By analyzing Guardant Health's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Guardant Health's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Guardant Health specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Payables Turnover | 4.39 | 7.52 | 8.64 | Days Of Inventory On Hand | 99.59 | 89.53 | 80.58 |
Guardant Health February 17, 2026 Technical Indicators
Most technical analysis of Guardant help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Guardant from various momentum indicators to cycle indicators. When you analyze Guardant charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.048 | |||
| Market Risk Adjusted Performance | 0.1349 | |||
| Mean Deviation | 2.02 | |||
| Semi Deviation | 2.64 | |||
| Downside Deviation | 2.8 | |||
| Coefficient Of Variation | 1975.67 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.94 | |||
| Information Ratio | 0.0258 | |||
| Jensen Alpha | 0.069 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.026 | |||
| Treynor Ratio | 0.1249 | |||
| Maximum Drawdown | 17.61 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 4.16 | |||
| Downside Variance | 7.82 | |||
| Semi Variance | 6.96 | |||
| Expected Short fall | (2.10) | |||
| Skewness | 0.2324 | |||
| Kurtosis | 2.31 |
Guardant Health February 17, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Guardant stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | 0.57 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 104.59 | ||
| Day Typical Price | 104.67 | ||
| Price Action Indicator | 1.31 | ||
| Market Facilitation Index | 3.67 |
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |